Clinical Trial Update: High-protein Oral Supplement Improves Normalized Protein Catabolic Rate and Inflammation Markers [NA]

View source ↗

Summary

Completed clinical trial indicates a high-protein oral supplement improves normalized protein catabolic rate and inflammation markers in patients with chronic k…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• High-protein oral supplement

Snippet

Sponsor: University of Florida | Conditions: Renal Failure, Chronic Kidney Disease Requiring Chronic Dialysis | NA | Status: COMPLETED